HIGHLIGHTS
- who: Hong-Xia Li and collaborators from the Department of Otorhinolaryngology Head and Neck Surgery, The Sixth Affiliated Hospital, Yat-sen University, Guangzhou, China have published the research work: Screening of Tumor Antigens and Construction of Immune Subtypes for mRNA Vaccine Development in Head and Neck Squamous Cell Carcinoma, in the Journal: Biomolecules 2023, 90 of 31/Dec/2022
- what: The aim of this study was to identify potential tumor antigens from publicly available databases for the development of an anti-HNSCC mRNA_vaccine and to determine the immune profile of HNSCC patients which would be . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.